Member Info for winnings1

If the story (recent RNS) is as good as it sounds, would the share price still be at this low level (1.85p).?
It would appear that there are many disbelievers.

Annoyingly not on LSE's site. You will find it on the website of 'Morningstar', search for INSE.

I can say it in three words: Excellent, Excellent, Exellent.

Focus on the underlying profit, the underlying EPS, that way it becomes clear that the shares are undervalued.
Shares of a profitable company operating in the medicines field deserve to trade on a high PE-Ratio. APH shares are, as yet, trading on a low PE-ratio, that is bound to change, IMHO.

People react as if it is the only well AMER has/had in sight. More drills to follow, success to follow.

Once again, Good Results (see RNS). T/O Rising, Profit Rising, Product Range Rising, Dividend Rising.
Sound and Safe for long term hold, IMHO.

Statcraft could well be one of the strategic investors, if not the very one on its own, £1.5m should be peanuts for the huge Norwegian Statkraft.
Watch this space....

"Discussions with potential strategic investors are progressing well", that is the clincher, once finances are in place, the share price is likely to rise very substantially.

Statcraft should get on with the job themselves and buy-up Redt, and put in place hard-nosed management.. This may well become the eventual outcome.

Why always these distant / remote connections, why not install the Redt storage units at existing UK solar panel stations.

I see a bit of movement in the right direction in the share price, this movement may well gain speed over the coming weeks as the shares are undervalued, i.e. cheap, IMO.

In my view IQE's management does not consist of hard enough nosed business men, more like academics running the show.

Management of Amer is wide awake and on the ball, today's news proves that.

I can say what I think of the situation it in three words: Hopeless, Hopeless and Hopeless.
Although I am not the most optimistic type of person, I think I am being quite realistic here.
I have said in the past repeatedly that Redt's management excels at making losses, I have
been proved correct..

Last Monday's RNS informs us that profit expectations for the current year ending 31 March will be met and that 2020 will be a year of strong performance. That to me suggests that the shares at current price of approximately 23p are undervalued and a pretty safe bet for delivering rises in the months/years ahead. But as always, don't take my word for it, DYOR or ask your financial adviser.

REDT is in deep sh.t and in my view unlikely to survive. The blame lies not with AIM but with management.
Plenty good companies on AIM. Just have a look at Advanced Medical Soltions (AMS), possibly the soundest company in the market, growing at a nice pace year by year and increasing its cash pile year by year.

The concern amongst small shareholders that Amer was running down reserves should after today's RNS be well and truly buried. Onwards and upwards from here on, iMO.

The thing to remember here at Redt is that management has a historic record of finding routes to potential losses.

The Directors know more than us, they were certainly not buying large scale for fun.

Good to see the excessive cash pile put to good use.